Research study Program year 2025 Source: CMS Open Payments

A Phase 1/2, First-Time-In Human (Ftih), Randomized, Observer-Blind, P

Research payments

$7,814,095

435 payments

Through program year 2025, $7,814,095 in research payments was reported against A Phase 1/2, First-Time-In Human (Ftih), Randomized, Observer-Blind, P, across 435 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$45,650	7
2024	Research	$511,043	29
2023	Research	$5,511,421	238
2022	Research	$1,745,980	161

Breakdown

Who paid Research payments · program years 2022–2025

GlaxoSmithKline, LLC. $7,814,095 435 payments

Who received the money Research payments · program years 2022–2025

Meridian Clinical Research LLC Organisation paid for research $1,447,565 49 payments
Pharmaseek LLC Organisation paid for research $1,003,838 35 payments
American Institute Of Research Organisation paid for research $836,123 36 payments
Johnson County Clinic Trials Organisation paid for research $797,266 37 payments
Pharmaseek Organisation paid for research $703,494 15 payments
Velocity Clinical Research INC Organisation paid for research $512,861 37 payments
Circuit Clinical Organisation paid for research $490,817 16 payments
Synexus Clinical Research US INC Organisation paid for research $399,326 32 payments
Bio Kinetic Clinical Organisation paid for research $396,981 30 payments
University Of Texas Medical Branch At Galveston Organisation paid for research $271,997 28 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

8 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.